ADG206-1001
03 Jan 2023
ADG206-1001
NCT05614258
Study of ADG206 in Subjects With Advanced/Metastatic Solid Tumors
Adagene Inc
Cancer Type | All cancers |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Locally Recurrent or Locally Advanced; Metastatic or Widespread |
Anticipated Start Date | 2022-12-01 |
Anticipated End Date | 2024-12-01 |
Hospital | Icon Cancer Centre Adelaide |
---|---|
Clinical Trial Coordinator | Sue Yeend |
sue.yeend@icon.team | |
Phone | 08 8292 2204 |
Principal Investigator | Dr Carolyn Bampton |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs